Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Exploring Novel Endocannabinoid Pathways in Sclerotic Chronic Graft-Versus-Host-Disease
SG
Sencer Göklemez
National Cancer Institute
SP
Steven Z. Pavletic
HC
Hyoyoung Choo‐Wosoba
National Institutes of Health
Ver todo
Puntos clave
Chronic graft-versus-host disease shows a potential link to novel endocannabinoid pathways, highlighting new areas for treatment.
A significant finding includes altered immune response markers which may inform future therapies.
Assessment using clinical observations and biomarker profiling reveals intricate relationships between sclerosis and endocannabinoids.
Understanding these pathways may enable the development of targeted therapies in patients with chronic graft-versus-host disease.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Exploring Novel Endocannabinoid Pathways in Sclerotic Chronic Graft-Versus-Host-Disease | Synapse
Cite This Study
Copy
Göklemez et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760d9c6e9836116a2dfab
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.357